Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Evotec and Takeda enter multi-RNA target alliance

March 23, 2021

Imperial psychedelic microdosing study pushes the envelope on participant blinding

March 5, 2021

Xencor and UCLA collaborate to develop novel therapeutic antibodies

Feb. 26, 2021

Careful with that BBB

Feb. 11, 2021

Predicting phase separation

Feb. 10, 2021

"Expansion sequencing" gives elbow room to in situ transcriptomics

Feb. 3, 2021

Curadigm's Nanoprimer-based project selected for Sanofi iTech Awards program

Jan. 26, 2021

Funding supports Vaxess' work on mRNA-based single-dose, refrigeration-free vaccine patch

Jan. 25, 2021

In situ-gelling hydrogel with tunable properties for intranasal drug delivery to the brain

Jan. 25, 2021

Organ-on-a-chip bests standard toxicity tests

Jan. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...